# Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors

> **NCT05855109** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1304 (actual)

## Conditions studied

- Arthritis, Rheumatoid
- Lung Diseases, Interstitial

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05855109
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-27
- **Primary completion:** 2025-06-19
- **Final completion:** 2025-06-26
- **Target enrollment:** 1304 (ACTUAL)
- **Last updated:** 2025-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05855109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05855109, "Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05855109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*